Last Updated: June 24, 2026

Claims for Patent: 4,724,231

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,724,231

Title:	Nasel compositions containing vitamin B12
Abstract:	This invention is directed to compositions for nasal administration of a vitamin B12 to a human suffering a vitamin B12 deficiency. It is also directed to such compositions in dosage unit form and with methods of administering such compositions.
Inventor(s):	Jeffrey Wenig
Assignee:	QOL Medical LLC
Application Number:	US06/848,690
Patent Claims:	1. A therapeutic composition for nasal administration comprising a therapeutically effective amount of a vitamin B12, a pharmaceutically acceptable isotonic aqueous buffer to provide a pH of from about 4 to 6 and sufficient pharmaceutically acceptable thickening agent so that the viscosity of the composition is from about 2500 to 10,000 cps. 2. A therapeutic composition of claim 1 wherein the vitamin B12 is cyanocobalamin. 3. A composition as in claim 1 or 2 additionally containing from about 1% to 10% by weight of a humectant. 4. A composition as in claim 1 or 2 additionally containing from about 0.2% to 2% by weight of a surfactant. 5. A composition as in claim 1 or 2 additionally containing from about 1% to 10% by weight of a humectant and from about 0.2% to 2% by weight of a surfactant. 6. A therapeutic composition as in claim 1 wherein the thickening agent is methyl cellulose. 7. A therapeutic composition of claim 6 wherein the vitamin B12 is cyanocobalamin. 8. A therapeutic composition of claim 6 or 7 additionally containing from about 1% to 10% by weight of a humectant and from about 0.2% to 2% by weight of a surfactant. 9. A therapeutic composition for nasal administration in dosage unit form comprising from 50 to 1000 micrograms of a vitamin B12, a pharmaceutically acceptable isotonic aqueous buffer to provide a pH of from about 4 to 6 and sufficient pharmaceutically acceptable thickening agent so that the viscosity of the composition is from about 2500 to 10,000 cps. 10. A therapeutic composition as in claim 9 wherein the vitamin B12 is cyanocobalamin. 11. A therapeutic composition as in claim 9 or 10 additionally containing from about 1% to 10% by weight of a humectant. 12. A therapeutic composition as in claim 9 or 10 additionally containing from about 0.2% to 2% by weight of a surfactant. 13. A therapeutic composition as in claim 9 or 10 additionally containing from about 1% to 10% by weight of a surfactant. 14. A therapeutic composition as in claim 9 wherein the thickening agent is methyl cellulose. 15. A therapeutic composition as in claim 14 wherein the vitamin B12 is a cyanocobalamin. 16. A therapeutic composition as in claim 14 or 15 additionally containing from about 1% to 10% by weight of a humectant and from about 0.2% to 2% by weight of a surfactant. 17. A method of treating a human for vitamin B12 deficiency which comprises nasal administering to a human in need of such treatment a composition comprising a therapeutically effective amount of a vitamin B12, a pharmaceutically acceptable isotonic aqueous buffer to provide a pH of from about 4 to 6 and sufficient pharmaceutically acceptable thickening agent so that the viscosity of the composition is from about 2500 to 10,000 cps. 18. A method as in claim 17 wherein the vitamin B12 is cyanocobalamin. 19. A method as in claim 17 or 18 wherein the composition additionally contains from about 1% to 10% by weight of a humectant. 20. A method as in claim 17 or 18 wherein the composition additionally contains from about 0.2% to 2% by weight of a surfactant. 21. A method as in claim 17 or 18 wherein the composition additionally contains from about 1% to 10% by weight of a humectant and from about 0.2% to 2% by weight of a surfactant. 22. A method as in claim 17 wherein the thickening agent is methyl cellulose. 23. A method as in claim 22 wherein the vitamin B12 is cyanocobalamin. 24. A method as in claim 22 or 23 wherein the composition additionally contains from about 1% to 10% by weight of a humectant and from about 0.2% to 2% by weight of a surfactant. 25. A composition as in claim 1 wherein the viscosity is from 2500 to 6500 cps. 26. A composition as in claim 9 wherein the viscosity is from 2500 to 6500 cps. 27. A method as in claim 17 wherein the viscosity of the composition is from 2500 to 6500 cps.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.